GlassScriptPhysician profile
Manuel Alejandro Cruz
NPI 1699302455
$528.84
in general payments reported to CMS, 2019-2025
13 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.15 · 2024: $207 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $125.00 | 2025 | |
| Abbvie INC. | $75.41 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.58 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $64.63 | 2024-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $40.47 | 2024 | |
| Exact Sciences Corporation | $31.51 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $20.95 | 2024 | Vaxneuvance, Gardasil 9, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.82 | 2025 | Lifevest |
| Glaxosmithkline, LLC. | $17.52 | 2024 | Shingrix, Arexvy, Bexsero |
| Sanofi Pasteur INC. | $16.53 | 2025 | |
| Cranial Technologies, INC | $16.28 | 2025 | Doc Band |
| Organon LLC | $15.15 | 2023 | Nexplanon |
| Hologic Sales and Service, LLC | $14.99 | 2024 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Cruz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.